Cosylab and Heron Neutron Medical Corp. Sign Letter of Intent to Advance Global Deployment of Accelerator-Based BNCT Systems

Contributed by: Business Wire

Logo

Tags

Hardware

Health Technology

Semiconductor

Other Health

Technology

Finance

Radiology

Business

Oncology

Professional Services

Hospitals

Science

Software

Other Science

Research

Health

Letter of Intent with Heron Neutron Medical Corp.

More Like This

ACCESSWIRE associated0

HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies

Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs

Biocytogen Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma

Cosylab Launches PlanOne™ Treatment Planning System for Particle Therapy

PR Newswire associated0

AtomVie Global Radiopharma and Radiopharm Theranostics Partner to Develop and Manufacture 177Lu-BetaBart Radioantibody for Treatment of Multiple Solid Tumors

CBC-Backed Hasten Biopharmaceutical Announces Acquisition of 14 Celltrion Legacy Products

Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific Antibody-Drug Conjugates

PR Newswire associated0

Cumulus Neuroscience to Join Bio-Hermes 2 Study with Funding from the Innovate UK Small Business Research Initiative (SBRI) Dementia Mission Project